Role of AP-1 and RE-1 binding sites in matrix metalloproteinase-2 transcriptional regulation in skeletal muscle atrophy

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 219-223

  Liu, Xuhui ^a,b   Manzano, Givenchy ^a,b   Lovett, David H ^a,b   Kim, Hubert T ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; Extracellular matrix; Gene expression regulation; Matrix metalloproteinase 2; Muscle atrophy; Transcription

Indexed keywords

GELATINASE A; RE 1 SILENCING TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 2; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

MUS;

EID: 77952746099     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.067     Document Type: Article

References (19)

1. Booth F.W., and Seider M.J. Recovery of skeletal muscle after 3 months of hindlimb immobilization in rats. J. Appl. Physiol. 47 (1979) 435-439
2. Meada H., Kimmel D.B., Raab D.M., and Lane N.E. Musculoskeletal recovery following hindlimb immobilization in adult female rats. Bone 14 (1993) 153-159
3. Zarzhevsky N., Carmeli E., Fuchs D., Coleman R., Stein H., and Reznick A.Z. Recovery of muscles of old rats after hindlimb immobilisation by external fixation is impaired compared with those of young rats. Exp. Gerontol. 36 (2001) 125-140
4. Choi H., Kondo S., Hirose K., Ishiguro N., Hasegawa Y., and Iwata H. Expression and enzymatic activity of MMP-2 during healing process of the acute supraspinatus tendon tear in rabbits. J. Orthop. Res. 20 (2002) 927-933
5. Russo T., Peviani S., Durigan J., and Salvini T. Electrical stimulation increases matrix metalloproteinase-2 gene expression but does not change its activity in denervated rat muscle. Muscle Nerve 37 (2008) 593-600
6. Skittone L.K., Liu X., Tseng A., and Kim H.T. Matrix metalloproteinase-2 expression and promoter/enhancer activity in skeletal muscle atrophy. J. Orthop. Res. 26 (2008) 357-363
7. Liu X., Lee D., Skittone L., Natsuhara K., and Kim H. Role of gelatinases in disuse-induced skeletal muscle atrophy. Muscle Nerve 41 (2010) 174-178
8. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
9. Nagase H., and Woessner J. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
10. Tsuruda T., Costello-Boerrigter L., and Burnett J. Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail. Rev. 9 (2004) 53-61
11. Bendeck M. Matrix metalloproteinases. Are they antiatherogenic but proaneurysmal?. Circ. Res. 90 (2002) 836-837
12. Bergman M., Cheng S., Honbo N., Piacentini L., Karliner J., and Lovett D. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem. J. 369 (2003) 485-496
13. Mertens P., Harendza S., Pollock A., and Lovett D. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem. 272 (1997) 22905-22912
14. Mertens P., Steinmann K., Alfonso-Jaume M., En-Nia A., Sun Y., and Lovett D. Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells. J. Biol. Chem. 277 (2002) 24875-24882
15. Alfonso-Jaume M., Bergman M., Mahimkar R., Cheng S., Jin Z., Karliner J., and Lovett D. Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1838-H1846
16. Lee J., Dahi S., Mahimkar R., Tulloch N., Alfonso-Jaume M., Lovett D., and Sarkar R. Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in disuse. Proc. Natl. Acad. Sci. USA 102 (2005) 16345-16350
17. Dahi S., Lee L., Lovett D., and Sarkar R. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin. J. Vasc. Surg. 42 (2005) 539-545
18. Haring M., Offermann S., Danker T., Horst I., Perterhanel C., and Stam M. Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization. Plant Methods 24 (2007) 3-11
19. Morris C., Morris L., Kennedy A., and Sweenay H. Attenuation of skeletal muscle atrophy via protease inhibition. J. Appl. Physiol. 99 (2005) 1719-1727